List of Excipients in API potassium chloride extended-release
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing potassium chloride extended-release
Detailed excipient profiles for potassium chloride extended-release
Excipient focus: CELLULOSE, MICROCRYSTALLINE
potassium chloride extended-release drug variants containing CELLULOSE, MICROCRYSTALLINE
potassium chloride extended-release drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: COPOVIDONE K25-31
potassium chloride extended-release drug variants containing COPOVIDONE K25-31
| Company | Ingredient | NDC |
|---|---|---|
| Solco Healthcare LLC | potassium chloride extended-release | 43547-549 |
| >Company | >Ingredient | >NDC |
potassium chloride extended-release drug variants not containing COPOVIDONE K25-31
Excipient focus: CROSCARMELLOSE SODIUM
potassium chloride extended-release drug variants containing CROSCARMELLOSE SODIUM
potassium chloride extended-release drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ETHYLCELLULOSE
potassium chloride extended-release drug variants containing ETHYLCELLULOSE
potassium chloride extended-release drug variants not containing ETHYLCELLULOSE
Excipient focus: ETHYLCELLULOSES
potassium chloride extended-release drug variants containing ETHYLCELLULOSES
potassium chloride extended-release drug variants not containing ETHYLCELLULOSES
Excipient focus: HYDROXYPROPYL CELLULOSE
potassium chloride extended-release drug variants containing HYDROXYPROPYL CELLULOSE
potassium chloride extended-release drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Solco Healthcare LLC | potassium chloride extended-release | 43547-549 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STEARYL FUMARATE
potassium chloride extended-release drug variants containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| Solco Healthcare LLC | potassium chloride extended-release | 43547-549 |
| >Company | >Ingredient | >NDC |
potassium chloride extended-release drug variants not containing SODIUM STEARYL FUMARATE
Excipient focus: TALC
potassium chloride extended-release drug variants containing TALC
potassium chloride extended-release drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Solco Healthcare LLC | potassium chloride extended-release | 43547-549 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
